+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on HIV Research and Clinical Trials · Registering as Listener

ICHRCT
📅 24 – 25 May 2027 📍 Chicago, USA 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on HIV Research and Clinical Trials
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9

This track will explore the latest innovations in molecular diagnostic techniques for HIV detection and monitoring. Emphasis will be placed on the integration of novel biomarkers and technologies in clinical practice.

This session will focus on cutting-edge therapeutic innovations aimed at improving patient outcomes in HIV management. Discussions will include novel antiretroviral therapies and combination strategies.

This track will highlight translational research efforts that aim to convert laboratory findings into clinical applications for HIV treatment and prevention. Participants will discuss the challenges and successes in this critical area.

This session will address the importance of patient-centered approaches in HIV care, including adherence strategies and psychosocial support. The role of healthcare providers in fostering patient engagement will also be examined.

This track will focus on the identification and validation of biomarkers that can predict disease progression in HIV-infected individuals. Researchers will present their findings on potential clinical applications of these biomarkers.

This session will discuss effective public health strategies aimed at reducing HIV transmission rates globally. Topics will include community-based interventions, education, and policy initiatives.

This track will cover advanced laboratory techniques utilized in HIV research, including cell culture, viral load testing, and genetic sequencing. Participants will share insights on optimizing these methodologies for enhanced research outcomes.

This session will delve into the underlying mechanisms of HIV pathogenesis and immune response. Researchers will present their latest findings on viral replication, host interactions, and immune evasion strategies.

This track will focus on the design and implementation of clinical trials in HIV research, including challenges in recruitment and retention. Best practices for ensuring trial integrity and participant safety will be discussed.

This session will provide a platform for discussing global perspectives on HIV research and clinical trials. Participants will share insights on regional challenges, successes, and collaborative efforts in combating HIV.

This track will explore the latest developments in HIV vaccine research, including novel approaches and clinical trial outcomes. The session will address the scientific and ethical considerations surrounding vaccine development.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED